Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, primary care and rheumatology business units. Horizon's global headquarters are in Dublin, Ireland.
Executive Vice President, Corporate Strategy and Investor Relations
U.S. Media Contact:
Senior Vice President, Corporate Communications
+1 888 506-2562
Ireland Media Contact
+353 (87) 2417373